Effects of Flos carthami on CYP2D6 and on the pharmacokinetics of metoprolol in rats

Evidence-based Complementary and Alternative Medicine

Volumn 2011, Issue , 2011, Pages

  Liu, Gaofeng ^a   Liu, Yan ^a   Liu, Rui ^a   Dong, Feng ^a   Zhang, Zhiren ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; CYTOCHROME P450 2D6; DEXTROMETHORPHAN; FLOS CARTHAMI EXTRACT; METOPROLOL; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG HALF LIFE; DRUG METABOLISM; FLOS CARTHAMI; HERBAL MEDICINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IC 50; MALE; MAXIMUM PLASMA CONCENTRATION; METABOLIC RATE; NONHUMAN; PRIORITY JOURNAL; RAT; RISK FACTOR; TIME TO MAXIMUM PLASMA CONCENTRATION;

EID: 79251555642     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2011/207076     Document Type: Article

References (32)

1. Bruno J. J., Ellis J. J., Herbal use among US elderly: 2002 National Health Interview Survey Annals of Pharmacotherapy 2005 39 4 643 648
2. Ernst E., Herbal medicinesthey are popular, but are they also safe? European Journal of Clinical Pharmacology 2006 62 1 1 2
3. Calapai G., Caputi A. P., Herbal medicines: can we do without pharmacologist? Evidence-Based Complementary and Alternative Medicine 2007 4 S1 41 43
4. Firenzuoli F., Gori L., Herbal medicine today: clinical and research issues Evidence-Based Complementary and Alternative Medicine 2007 4 1 37 40
5. Chavez M. L., Jordan M. A., Chavez P. I., Evidence-based drug-herbal interactions Life Sciences 2006 78 18 2146 2157
6. de Smet P. A., Clinical risk management of herb-drug interactions British Journal of Clinical Pharmacology 2006 63 6 258 267
7. Barnes J., Pharmacovigilance of herbal medicines: a UK perspective Drug Safety 2003 26 12 829 851
8. MacPherson H., Liu B., The safety of Chinese herbal medicine: a pilot study for a national survey Journal of Alternative and Complementary Medicine 2005 11 4 617 626
9. Tovar R. T., Petzel R. M., Herbal toxicity Disease-A-Month 2009 55 10 592 641
10. Zhuge J., Yu Y.-N., Wu X.-D., Stable expression of human cytochrome P450 2D 6 10 in HepG2 cells World Journal of Gastroenterology 2004 10 2 234 237
11. Li Q., Wang R., Genetic polymorphism of CYP2D6 and drug interactions Chinese Journal of Clinical Pharmacology and Therapeutics 2006 4 369 374
12. Zhou S., Gao Y., Jiang W., Huang M., Xu A., Paxton J. W., Interactions of herbs with cytochrome P450 Drug Metabolism Reviews 2003 35 1 35 98
13. Hu Z., Yang X., Ho P. C. L., Sui Y. C., Heng P. W. S., Chan E., Duan W., Hwee L. K., Zhou S., Herb-drug interactions: a literature review Drugs 2005 65 9 1239 1282
14. Izzo A. A., Ernst E., Interactions between herbal medicines and prescribed drugs: an updated systematic review Drugs 2009 69 13 1777 1798
15. Rodeiro I., Donato M. T., Jimenez N., Garrido G., Molina-Torres J., Menendez R., Castell J. V., Gmez-Lechn M. J., Inhibition of human P450 enzymes by natural extracts used in traditional medicine Phytotherapy Research 2009 23 2 279 282
16. Gibbson C. G., Sheet P., Introduction to Drug Metabolism 1994 2nd New York, NY, USA Blackie Academic and Professional
17. Bradford M. M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding Analytical Biochemistry 1976 72 1-2 248 254
18. Bjornsson T. D., Callaghan J. T., Einolf H. J., Fischer V., Gan L., Grimm S., Kao J., King S. P., Miwa G., Ni L., Kumar G., McLeod J., Obach R. S., Roberts S., Roe A., Shah A., Snikeris F., Sullivan J. T., Tweedie D., Vega J. M., Walsh J., Wrighton S. A., The conduct of in vitro and in vivo drug-drug interaction studies: a pharmaceutical research and manufacturers of America (PhRMA) perspective Drug Metabolism and Disposition 2003 31 7 815 832
19. Martnez C., Albet C., Agndez J. A. G., Herrero E., Carrillo J. A., Mrquez M., Bentez J., Ortiz J. A., Comparative in vitro and in vivo inhibition of cytochrome P450 CYP1A2, CYP2D6, and CYP3A by H2 -receptor antagonists Clinical Pharmacology and Therapeutics 1999 65 4 369 376
20. Hotta Y., Nagatsu A., Liu W., Muto T., Narumiya C., Lu X., Yajima M., Ishikawa N., Miyazeki K., Kawai N., Mizukami H., Sakakibara J., Protective effects of antioxidative serotonin derivatives isolated from safflower against postischemic myocardial dysfunction Molecular and Cellular Biochemistry 2002 238 1-2 151 162
21. Wanger H., Bauer R., Xiao P. G., Chen J. M., Bcher S., Flos Carthami (Honghua), (Einzelexemplar) Drug Monographs and Analysis 2006 7 Wald, Germany fr Ganzheitliche Medizin
22. Han S.-Y., Li H.-X., Ma X., Zhang K., Ma Z.-Z., Tu P.-F., Protective effects of purified safflower extract on myocardial ischemia in vivo and in vitro Phytomedicine 2009 16 8 694 702
23. Yang L. H., Zang M., Ma V., Yang G., Modern research development of Flos Carthami Chinese Journal of Gerontology 2007 27 7 1429 1430
24. Yu S. J., Liu J., Clinical application of Flos Carthami and Flos Carthami injection Journal of Practical Traditional Chinese Internal Medicine 2007 21 6 28
25. Zhen Y. L., Clinical observation of Flos Carthami injection on 30 unstable angina pectoris patients Journal of Emergency in Traditional Chinese Medicine 2004 2 13 84
26. Hu O. Y.-P., Tang H.-S., Lane H.-Y., Chang W.-H., Hu T.-M., Novel single-point plasma or saliva dextromethorphan method for determining CYP2D6 activity Journal of Pharmacology and Experimental Therapeutics 1998 285 3 955 960
27. Mortimer., Lindstrom B., Laurell H., Bergman U., Rane A., Dextromethorphan: polymorphic serum pattern of the O-demethylated and didemethylated metabolites in man British Journal of Clinical Pharmacology 1989 27 2 223 227
28. Yu A.-M., Idle J. R., Gonzalez F. J., Polymorphic cytochrome P450, 2D6: hamanized mouse model and endogenous substrates Drug Metabolism Reviews 2004 36 2 243 277
29. Zanger U. M., Raimundo S., Eichelbaum M., Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry Naunyn-Schmiedeberg's Archives of Pharmacology 2004 369 1 23 37
30. Takahashi K., Uejima E., Morisaki T., Takahashi K., Kurokawa N., Azuma J., In vitro inhibitory effects of Kampo medicines on metabolic reactions catalyzed by human liver microsomes Journal of Clinical Pharmacy and Therapeutics 2003 28 4 319 327
31. Ito K., Satoh T., Watanabe Y., Ikarashi N., Asano T., Morita T., Sugiyama K., Effects of Kampo medicines on CYP and P-gp activity in vitro Biological and Pharmaceutical Bulletin 2008 31 5 893 896
32. Gurley B. J., Swain A., Hubbard M. A., Williams D. K., Barone G., Hartsfield F., Tong Y., Carrier D. J., Cheboyina S., Battu S. K., Clinical assessment of CYP2D6-mediated herb-drug interactions in humans: effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and Echinacea Molecular Nutrition and Food Research 2008 52 7 755 763